PeproTech - support life science research, cellular therapy and regenerative medicine

Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

References

First Author

Ocaña-Guzmán, R

Title

Leukocytes from Patients with Drug-Sensitive and Multidrug-Resistant Tuberculosis Exhibit Distinctive Profiles of Chemokine Receptor Expression and Migration Capacity.

Citation

Journal of immunology research; 2021; 2021 pg6654220

PubMed ID

33977111

Show Usages

300-04

Human

Chemotaxis Assay

300-30

Human

Chemotaxis Assay

300-12

Human

Chemotaxis Assay

200-08

Human

Chemotaxis Assay

First Author

Fang, W B

Title

Expression of CCL2/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression

Citation

Scientific reports; 2021 Apr 22; 11(1) pg8708

PubMed ID

33888841

Show Usages

300-04

Human

in vitro

First Author

Xu, W W

Title

Direct Targeting of CREB1 with Imperatorin Inhibits TGFβ2-ERK Signaling to Suppress Esophageal Cancer Metastasis.

Citation

Advanced science (Weinheim, Baden-Wurttemberg, Germany); 2020 Aug; 7(16) pg2000925

PubMed ID

32832354

Show Usages

100-35

Human

in vitro

300-04

Human

in vitro

First Author

Bluhmki, T

Title

Development of a miniaturized 96-Transwell air-liquid interface human small airway epithelial model.

Citation

Scientific reports; 2020 Aug 3; 10(1) pg13022

PubMed ID

32747751

Show Usages

300-04

Human

ELISA

First Author

Meyrath, M

Title

The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides

Citation

Nature communications; 2020 Jun 19; 11(1) pg3033

PubMed ID

32561830

Show Usages

300-46

Human

in vitro

300-28A

Human

in vitro

300-04

Human

in vitro

First Author

Layton, T B

Title

Cellular census of human fibrosis defines functionally distinct stromal cell types and states.

Citation

Nature communications; 2020 Jun 2; 11(1) pg2768

PubMed ID

32488016

Show Usages

300-04

Human

in vitro

First Author

Murcia, J D

Title

Atypical chemokine receptor ACKR2-V41A has decreased CCL2 binding, scavenging, and activation, supporting sustained inflammation and increased Alzheimer's disease risk

Citation

Scientific reports; 2020 May 15; 10(1) pg8019

PubMed ID

32415244

Show Usages

300-04

Human

in vitro

300-09

Human

in vitro

900-T31